vs
Side-by-side financial comparison of Local Bounti Corporation (LOCL) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $12.5M, roughly 1.5× Local Bounti Corporation). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -69.8%, a 66.8% gap on every dollar of revenue. On growth, Local Bounti Corporation posted the faster year-over-year revenue change (23.7% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-3.6M). Over the past eight quarters, Local Bounti Corporation's revenue compounded faster (21.9% CAGR vs -10.1%).
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
LOCL vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $18.3M |
| Net Profit | $-8.7M | $-554.0K |
| Gross Margin | 12.2% | 21.1% |
| Operating Margin | -106.1% | -2.2% |
| Net Margin | -69.8% | -3.0% |
| Revenue YoY | 23.7% | -25.6% |
| Net Profit YoY | 76.0% | 26.7% |
| EPS (diluted) | $1.52 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.5M | $18.3M | ||
| Q3 25 | $12.2M | $15.9M | ||
| Q2 25 | $12.1M | $16.1M | ||
| Q1 25 | $11.6M | $18.9M | ||
| Q4 24 | $10.1M | $24.7M | ||
| Q3 24 | $10.2M | $28.3M | ||
| Q2 24 | $9.4M | $25.8M | ||
| Q1 24 | $8.4M | $22.7M |
| Q4 25 | $-8.7M | $-554.0K | ||
| Q3 25 | $-26.4M | $-1.8M | ||
| Q2 25 | $-21.6M | $-1.5M | ||
| Q1 25 | $-37.7M | $-1.5M | ||
| Q4 24 | $-36.3M | $-756.0K | ||
| Q3 24 | $-34.3M | $1.7M | ||
| Q2 24 | $-25.3M | $343.0K | ||
| Q1 24 | $-24.1M | $-1.7M |
| Q4 25 | 12.2% | 21.1% | ||
| Q3 25 | 11.5% | 14.3% | ||
| Q2 25 | 12.2% | 15.6% | ||
| Q1 25 | 12.6% | 16.1% | ||
| Q4 24 | 5.4% | 14.7% | ||
| Q3 24 | 13.8% | 22.0% | ||
| Q2 24 | 14.3% | 17.6% | ||
| Q1 24 | 9.4% | 13.5% |
| Q4 25 | -106.1% | -2.2% | ||
| Q3 25 | -149.4% | -9.9% | ||
| Q2 25 | -127.7% | -8.4% | ||
| Q1 25 | -135.6% | -7.2% | ||
| Q4 24 | -166.6% | -2.1% | ||
| Q3 24 | -176.0% | 6.8% | ||
| Q2 24 | -146.8% | 2.0% | ||
| Q1 24 | -122.9% | -5.8% |
| Q4 25 | -69.8% | -3.0% | ||
| Q3 25 | -216.6% | -11.0% | ||
| Q2 25 | -178.3% | -9.3% | ||
| Q1 25 | -324.6% | -8.0% | ||
| Q4 24 | -360.1% | -3.1% | ||
| Q3 24 | -335.2% | 5.9% | ||
| Q2 24 | -267.6% | 1.3% | ||
| Q1 24 | -286.9% | -7.6% |
| Q4 25 | $1.52 | $-0.01 | ||
| Q3 25 | $-1.18 | $-0.05 | ||
| Q2 25 | $-1.63 | $-0.05 | ||
| Q1 25 | $-4.32 | $-0.04 | ||
| Q4 24 | $-4.24 | $-0.02 | ||
| Q3 24 | $-4.01 | $0.04 | ||
| Q2 24 | $-3.00 | $0.01 | ||
| Q1 24 | $-2.89 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $10.7M |
| Total DebtLower is stronger | $483.1M | — |
| Stockholders' EquityBook value | $-166.2M | $37.0M |
| Total Assets | $410.5M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $10.7M | ||
| Q3 25 | $6.2M | $13.6M | ||
| Q2 25 | $5.3M | $12.5M | ||
| Q1 25 | $18.0M | $11.4M | ||
| Q4 24 | $937.0K | $15.7M | ||
| Q3 24 | $317.0K | $12.3M | ||
| Q2 24 | $9.7M | $11.9M | ||
| Q1 24 | $8.2M | $6.6M |
| Q4 25 | $483.1M | — | ||
| Q3 25 | $484.9M | — | ||
| Q2 25 | $478.3M | — | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $436.8M | — | ||
| Q3 24 | $398.4M | — | ||
| Q2 24 | $374.0M | — | ||
| Q1 24 | $329.8M | — |
| Q4 25 | $-166.2M | $37.0M | ||
| Q3 25 | $-158.1M | $37.0M | ||
| Q2 25 | $-132.7M | $30.4M | ||
| Q1 25 | $-134.5M | $31.5M | ||
| Q4 24 | $-100.5M | $32.6M | ||
| Q3 24 | $-65.6M | $29.1M | ||
| Q2 24 | $-32.8M | $23.5M | ||
| Q1 24 | $-9.4M | $20.6M |
| Q4 25 | $410.5M | $57.1M | ||
| Q3 25 | $417.8M | $57.5M | ||
| Q2 25 | $426.8M | $52.6M | ||
| Q1 25 | $447.2M | $54.0M | ||
| Q4 24 | $428.0M | $59.2M | ||
| Q3 24 | $430.8M | $57.1M | ||
| Q2 24 | $438.1M | $53.0M | ||
| Q1 24 | $413.4M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.1M | $2.3M |
| Free Cash FlowOCF − Capex | $-3.6M | $2.2M |
| FCF MarginFCF / Revenue | -29.1% | 12.0% |
| Capex IntensityCapex / Revenue | 3.9% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.9M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.1M | $2.3M | ||
| Q3 25 | $-8.9M | $-1.3M | ||
| Q2 25 | $-8.7M | $1.8M | ||
| Q1 25 | $-9.6M | $-3.5M | ||
| Q4 24 | $1.2M | $865.0K | ||
| Q3 24 | $-17.2M | $4.3M | ||
| Q2 24 | $-4.0M | $1.4M | ||
| Q1 24 | $-7.1M | $-2.4M |
| Q4 25 | $-3.6M | $2.2M | ||
| Q3 25 | $-10.1M | $-1.5M | ||
| Q2 25 | $-14.6M | $1.7M | ||
| Q1 25 | $-14.5M | $-3.5M | ||
| Q4 24 | $-8.6M | $470.0K | ||
| Q3 24 | $-30.0M | $4.1M | ||
| Q2 24 | $-28.8M | $1.2M | ||
| Q1 24 | $-42.1M | $-2.5M |
| Q4 25 | -29.1% | 12.0% | ||
| Q3 25 | -82.8% | -9.6% | ||
| Q2 25 | -121.0% | 10.5% | ||
| Q1 25 | -125.1% | -18.8% | ||
| Q4 24 | -85.3% | 1.9% | ||
| Q3 24 | -293.1% | 14.4% | ||
| Q2 24 | -305.4% | 4.5% | ||
| Q1 24 | -501.8% | -11.1% |
| Q4 25 | 3.9% | 0.5% | ||
| Q3 25 | 9.7% | 1.4% | ||
| Q2 25 | 48.9% | 1.0% | ||
| Q1 25 | 42.8% | 0.3% | ||
| Q4 24 | 97.6% | 1.6% | ||
| Q3 24 | 125.0% | 0.7% | ||
| Q2 24 | 263.0% | 1.1% | ||
| Q1 24 | 417.3% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOCL
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
